...
首页> 外文期刊>Clinical and experimental nephrology >Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.
【24h】

Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.

机译:撤消腹膜透析后恢复腹膜完整性:处于包囊性腹膜硬化风险中的患者的特征。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The epidemiological characteristics of encapsulating peritoneal sclerosis (EPS), such as its high incidence in patients with long-term peritoneal dialysis (PD) treatment, and the onset of EPS after patients are switched to hemodialysis (HD) may indicate an activated pathological process after PD withdrawal, especially in long-term PD patients. Accordingly, we aimed to observe changes in peritoneal function after the stoppage of PD, and to clarify the characteristic features of the patients at risk of EPS. METHODS: Thirty-three patients who were switched from continuous ambulatory peritoneal dialysis (CAPD) to HD were enrolled in this trial. Changes in the dialysate/plasma creatinine (D/P Cr) and CA125 levels in the effluent of the peritoneal equilibration test were observed for 6 months. Furthermore, each patient was followed-up for 36 months after PD withdrawal to monitor for the development of EPS. RESULTS: D/P Cr decreased significantly, while CA125 levels tended to increase. Nine patients developed EPS during the follow-up period and they specifically showed significant increases of D/P Cr levels and significantly lower levels of CA125 at PD withdrawal. The accumulation of high transporters in the EPS group at 0 and 6 months after PD withdrawal was significant. CONCLUSIONS: Peritoneal recovery may take place after withdrawal from PD treatment and such recover indicated by improvement of transport states and a rise of the CA125 level. The present study revealed that a high-transport state and lack of increase of CA125 in the effluent were associated with EPS development after PD withdrawal. This may suggest that the lack of peritoneal recovery after PD withdrawal is predictive for EPS development.
机译:背景:包膜性腹膜硬化症(EPS)的流行病学特征,例如长期腹膜透析(PD)治疗中的高发病率,以及患者改用血液透析(HD)后的发作可能表明病理性激活PD停药后的治疗过程,尤其是长期PD患者。因此,我们旨在观察PD停药后腹膜功能的变化,并阐明有EPS风险的患者的特征。方法:本研究纳入了33例从连续门诊腹膜透析(CAPD)改为HD的患者。观察腹膜平衡试验流出液中的透析液/血浆肌酐(D / P Cr)和CA125水平的变化。此外,每位患者停药后均应随访36个月,以监测EPS的发展。结果:D / P Cr显着降低,而CA125含量则呈上升趋势。 9名患者在随访期间出现了EPS,并且在停药后具体表现出D / P Cr水平显着增加和CA125水平显着降低。 PD撤离后0个月和6个月,EPS组中的高转运蛋白积累显着。结论:PD治疗停药后可能发生腹膜恢复,这种恢复表现为运输状态改善和CA125水平升高。本研究表明,PD撤离后,EPS的发展与高运输状态和污水中CA125缺乏增加有关。这可能提示PD停药后腹膜恢复不足是EPS发展的预兆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号